Clinical Trial Update: Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study [Phase 1]

View source ↗

Summary

A Phase 1 trial of Aeris Therapeutics' Biologic Lung Volume Reduction for emphysema and related COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Emphysema

Drugs mentioned

• Biologic Lung Volume Reduction (BLVR)

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED